Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Brian Schall / United States — Food and Drug Administration

Brian Schall & United States — Food and Drug Administration

2 shared events · Importance 3 · Last updated Apr 27, 2026

Importance
3
Shared Events
2
Actions
0
Sentiment
21.666666666666668
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (2)
17
Regulatory
Atara Biotherapeutics Faces Securities Lawsuit
Brian Schall: Brian Schall is associated with The The Schall Law Firm and is encouraging investors to contact the firm regarding the class action lawsuit.
United States — Food and Drug Administration: The United States — Food and Drug Administration's potential non-approval of Atara Biotherapeutics' BLA for tabelecleucel due to manufacturing problems and study deficiencies is a key point in the lawsuit.
May 01, 2026 · 6 articles
0
Business
UniQure Securities Fraud Class Action
Apr 02, 2026 · 20 articles
NEWSDESK
Explore this relationship live

Track how Brian Schall and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.